Rezultati pretrage - E. S. Kropacheva

SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS od E. S. Kropacheva

Connect to this object online.

SAFETY ISSUES IN THE TREATMENT OF PATIENTS TAKING DABIGATRAN od E. S. Kropacheva

Connect to this object online.

SAFETY OF THERAPY AND PATRONAGE SYSTEM IN PATIENTS WHO RECEIVE WARFARIN od E. S. Kropacheva

Connect to this object online.

Intracardiac thrombosis: frequency, risk factors and place of oral anticoagulants in treatment od E. S. Kropacheva

Connect to this object online.

SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS od E. S. Kropacheva

Connect to this object online.

SELECTING AN OPTIMAL LONG-TERM ANTICOAGULANT THERAPY FOR A PATIENT WITH ATRIAL FIBRILLATION AND RECURRENT MINOR HEMORRHAGE. CLINICAL FOLLOW-UP od E. S. Kropacheva, E. P. Panchenko

Connect to this object online.

The place of dabigatran in the treatment of patients with atrial fibrillation in the light of modern recommendations od E. S. Kropacheva, E. P. Panchenko

Connect to this object online.

Aspects of anticoagulant therapy in patients with atrial fibrillation in the light of updated guidelines of the European society of cardiology 2020: the position of dabigatran od E. S. Kropacheva, E. P. Panchenko

Connect to this object online.

ASPECTS OF MULTICOMPONENT THERAPY AND PERIOPERATIVE TACTICS IN A PATIENT WITH ATRIAL FIBRILLATION RECEIVING RIVAROXABAN THERAPY. CLINICAL OBSERVATION od O. A. Zemlyanskaya, E. S. Kropacheva

Connect to this object online.

Rivaroxaban in patients with atrial fibrillation: from research to real practice (based on REGistry of Long-term AnTithrombotic TherApy-2 (REGATA)) od E. S. Kropacheva, E. N. Krivosheeva, E. P. Panchenko

Connect to this object online.

CLINICAL FACTORS AND ANTICOAGULATION LEVEL THAT DETERMINE THE SUDDEN LOSS OF KIDNEY FUNCTION IN PATIENTS LONG-TAKING WARFARIN (A 5-YEAR PROSPECTIVE, OBSERVATIONAL STUDY) od E. S. Kropacheva, O. A. Zemlyanskaya, A. В. Dobrovolsky, Е. P. Panchenko

Connect to this object online.

THE EFFICACY OF LONG-TERM WARFARIN THERAPY: THE IMPACT ON THE INCIDENCE OF ISCHEMIC CEREBROVASCULAR DISORDERS AND CLINICAL PREDICTORS OF DEVELOPING SUCH DISORDERS. (Results of a pr... od E. S. KROPACHEVA, O. A. ZEMLYANSKAYA, A. B. DOBROVOLSKY, E. P. PANCHENKO

Connect to this object online.

Need to determine the residual concentrations of direct oral anticoagulants in patients with atrial fibrillation undergoing transcatheter implantation of the aortic valve od A. I. Staroverova, E. S. Kropacheva, A. B. Dobrovolsky, E. V. Titaeva, E. P. Panchenko

Connect to this object online.

SAFETY OF LONG-TERM THERAPY WITH WARFARIN: HEMORRHAGE FREQUENCY AND CLINICAL PREDICTORS (results of a prospective 15-year follow-up) od E. S. Kropacheva, O. A. Zemlyanskaya, E. P. Panchenko, A. B. Dobrovolsky, E. N. Krivosheeva

Connect to this object online.

Modern possibilities and prospects in evaluating the anticoagulant effect of direct oral anticoagulants od A. I. Mironova, E. S. Kropacheva, A. B. Dobrovolsky, E. V. Titaeva, E. P. Panchenko

Connect to this object online.